Quick Answer
Protara Therapeutics, Inc. reported Total Assets of $209.47 million for fiscal year 2025.
Protara Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $209.47M | +15.4% |
| 2024 | $181.45M | +129.8% |
| 2023 | $78.95M | -30.3% |
| 2022 | $113.29M | -34.4% |
| 2021 | $172.60M | -15.0% |
| 2020 | $203.16M | +16511.4% |
| 2019 | $1.22M | -94.8% |
| 2018 | $23.52M | -46.5% |
| 2017 | $43.98M | +1.1% |
| 2016 | $43.52M | -35.6% |
| 2015 | $67.54M | -20.4% |
| 2014 | $84.80M | +1398.5% |
| 2013 | $5.66M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $144.64M | +53.7% | -7.8% |
| June 30, 2025 | $156.93M | +54.4% | -6.9% |
| March 31, 2025 | $168.56M | +147.4% | -7.1% |
| December 31, 2024 | $181.45M | +129.8% | +92.9% |
| September 30, 2024 | $94.09M | +6.4% | -7.4% |
| June 30, 2024 | $101.65M | +6.8% | +49.2% |
| March 31, 2024 | $68.13M | -36.0% | -13.7% |
| December 31, 2023 | $78.95M | -30.3% | -10.8% |
- Protara Therapeutics, Inc. showed an increase of +15.4% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Protara Therapeutics, Inc.’s total assets has grown by 3601.5% (from $5.66 million to $209.47 million).
- The most recent figure is from Protara Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: